Arena Pharma (ARNA) Tops Q3 EPS by 2c

Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19 million versus the consensus estimate of $13.99 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance